Jack Y. Zhang, CEO & Chief Science Officer, 10% Owner at Amphastar Pharmaceuticals, Inc. (AMPH), sold 187,619 shares at $16.37 ($3.0M) on 2015-06-10, disclosed to the SEC on 2015-06-12.
Scheduled sale ($3.0M) by CEO & Chief Science Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.46 | 4,831 | $80K | 2.6% |
| 2 | $16.47 | 6,173 | $102K | 3.3% |
| 3 | $16.61 | 3,046 | $51K | 1.7% |
| 4 | $16.61 | 3,052 | $51K | 1.7% |
| 5 | $16.23 | 2,633 | $43K | 1.4% |
| 6 | $16.24 | 2,624 |
| $43K |
| 1.4% |
| 7 | $16.37 | 11,411 | $187K | 6.1% |
| 8 | $16.37 | 1,208 | $20K | 0.6% |
| 9 | $16.38 | 11,731 | $192K | 6.3% |
| 10 | $16.38 | 1,244 | $20K | 0.7% |
| 11 | $16.47 | 1,266 | $21K | 0.7% |
| 12 | $16.47 | 11,664 | $192K | 6.3% |
| 13 | $16.47 | 1,260 | $21K | 0.7% |
| 14 | $16.15 | 7,635 | $123K | 4.0% |
| 15 | $16.15 | 75,618 | $1.2M | 40.1% |
| 16 | $16.17 | 3,752 | $61K | 2.0% |
| 17 | $16.17 | 38,471 | $622K | 20.4% |
| Total | $16.25 avg | 187,619 | $3.0M | 100% |
| Filing → |
| AMPH | SELL | 2021-02-18 | $1.1M | — | Filing → |
| AMPH | SELL | 2021-02-12 | $1.8M | — | Filing → |
| AMPH | SELL | 2021-02-09 | $1.5M | — | Filing → |